New Key Statistics Module, Z-Score and F-Score
NYSE:WST Key Ratios
Market Cap $ M | 26,589.21 |
Enterprise Value $ M | 26,294.01 |
P/E(ttm) | 48.16 |
PE Ratio without NRI | 47.65 |
Forward PE Ratio | 48.78 |
Price/Book | 9.94 |
Price/Sales | 9.34 |
Price/Free Cash Flow | 70.95 |
Price/Owner Earnings | 55.58 |
Payout Ratio % | 0.10 |
Revenue (TTM) $ M | 2,928.00 |
EPS (TTM) $ | 7.58 |
Beneish M-Score | -2.75 |
10-y EBITDA Growth Rate % | 15.00 |
5-y EBITDA Growth Rate % | 22.00 |
y-y EBITDA Growth Rate % | 5.70 |
EV-to-EBIT | 38.90 |
EV-to-EBITDA | 32.18 |
PEG | 2.17 |
Shares Outstanding M | 72.84 |
Net Margin (%) | 19.42 |
Operating Margin % | 22.71 |
Pre-tax Margin (%) | 22.79 |
Quick Ratio | 1.95 |
Current Ratio | 2.61 |
ROA % (ttm) | 15.30 |
ROE % (ttm) | 20.38 |
ROIC % (ttm) | 21.53 |
Dividend Yield % | 0.22 |
Altman Z-Score | 20.50 |
WST Number of Guru Trades
WST Volume of Guru Trades
Gurus Latest Trades with NYSE:WST
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:WST is held by these investors
Total 4
West Pharmaceutical Services Inc Insider Transactions
No Available Data
News about NYSE:WST
Total 0- 1